Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 25, Number 1—January 2019

Dengue Virus IgM Serotyping by ELISA with Recombinant Mutant Envelope Proteins

Alexandra Rockstroh, Luisa Barzon, Widuranga Kumbukgolla, Hoang Xuan Su, Erley Lizarazo, Maria Fernanda Vincenti-Gonzalez, Adriana Tami, Alice M.M. Ornelas, Renato Santana Aguiar, Daniel Cadar, Jonas Schmidt-Chanasit, and Sebastian UlbertComments to Author 
Author affiliations: Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany (A. Rockstroh, S. Ulbert); University of Padova, Padova, Italy (L. Barzon); Rajarata University of Sri Lanka, Mihinthale, Sri Lanka (W. Kumbukgolla); Vietnam Military Medical University, Hanoi, Vietnam (H.X. Su); University Medical Center Groningen, Groningen, the Netherlands (E. Lizarazo, M.F. Vincenti-Gonzalez, A. Tami); Federal University of Rio de Janeiro, Rio de Janeiro, Brazil (A.M.M. Ornelas, R.S. Aguiar); Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany (D. Cadar, J. Schmidt-Chanasit); German Centre for Infection Research, Hamburg (J. Schmidt-Chanasit)

Main Article

Table 2

Dominant serotype determined by DENV serotype–specific IgM ELISA among DENV PCR–negative cohort (n = 14), Vietnam, 2013–2018*

No. (%) samples with dominant serotype DENV serotype No. (%) samples
13 (92.86) 1 10/14 (71.43)
2 3/14 (21.43)

*DENV, dengue virus.

Main Article

Page created: December 18, 2018
Page updated: December 18, 2018
Page reviewed: December 18, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.